Asset Planning Services (Pennsylvania)’s Myriad Genetics MYGN Stock Holding History

Asset Planning Services (Pennsylvania)’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-200	Closed	-$5K	–	308
2017 Q2	$5K	Hold	200	–	–	﹤0.01%	262
2017 Q1	$4K	Hold	200	–	–	﹤0.01%	261
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	253
2016 Q3	$4K	Hold	200	–	–	﹤0.01%	236
2016 Q2	$6K	Hold	200	–	–	0.01%	224
2016 Q1	$7K	Hold	200	–	–	0.01%	211
2015 Q4	$9K	Hold	200	–	–	0.01%	173
2015 Q3	$7K	Hold	200	–	–	0.01%	176
2015 Q2	$7K	Buy	+200	New	+$6.8K	0.01%	194

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Asset Planning Services (Pennsylvania)'s MYGN Position: Q3 2017 in Review

Asset Planning Services (Pennsylvania) sold out of Myriad Genetics (MYGN) in Q3 2017, closing a stake of 200 shares — an estimated $5K sold.

Asset Planning Services (Pennsylvania) first reported a position in MYGN in Q2 2015 and held it in 9 quarters. The position peaked at $9K in Q4 2015. 220 funds tracked by Wall St. Rank hold MYGN as of Q3 2017.

Asset Planning Services (Pennsylvania) reported no remaining Myriad Genetics position as of Q3 2017 after selling out during the quarter.
Asset Planning Services (Pennsylvania) sold 200 Myriad Genetics shares in Q3 2017, an estimated $5K.
Asset Planning Services (Pennsylvania) first reported a position in Myriad Genetics in Q2 2015 and held it in 9 quarters.
Asset Planning Services (Pennsylvania)'s Myriad Genetics position peaked at $9K in Q4 2015.
220 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2017.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q3 2017, filed 30 Nov 2017.